ARCHIVES

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995

Substance From Sea Squirts In Phase II For Breast Cancer

November 29, 2002

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds

December 3, 1999

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012